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Abstract: Two new compounds, ethylconiferin (1) and (−)-lariciresinol 
4-(6'''-O-cinnamyl-β-D-glucopyranoside) (2), along with the three known compounds 
(+)-pinoresinol (3), (+)-cycloolivil (4), nobiletin (5), were isolated from the root of 
Jasminum girialdii. All these compounds were isolated for the first time from this source. 
Their structures were elucidated on the basis of extensive spectroscopic analysis and 
chemical methods. In addition, the in vitro cytotoxic activity of these compounds was 
evaluated. The results showed that none of the compounds had any significant inhibitory 
activities on the proliferation of HCT-116 and SW-620 cells.  
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1. Introduction 
Jasminum giraldii Diels (Oleaceae), is an endemic plant which is found distributed at an altitude of 
300–1,500 m, in valleys and shrubbery of the Qinba Mountains in China’s Shaanxi Province [1], Its 
dried roots, named as “quan pi” in Chinese, are used as a traditional local herb for the treatment of 
various diseases, such as fractures, traumatic injury and blood stasis, while some other species of this genus 
are employed to treat dysmenorrhea, metritis, leucorrhoea, galactophoritis, puerperal infection, irregular 
menstruation, hyperthermia, arthralgia, pain due to ischemia, dermatitis [2], fever, rheumatic pain [3], 
dysenteric diarrhea, trachelopanus, eczema [4], giddiness, edema [5] in Traditional Chinese Medicine. 
The chemistry and pharmacology of the ethanol extracts of the roots of J. giraldii have never been 
systematically investigated. As part of a program to acquire and assess potent chemicals in several 
traditional Chinese medicines for the preservation and treatment of colorectal cancer [6–9], an ethanolic 
extract of the root of J. giraldii has been investigated. We describe herein the isolation and structural 
elucidation of two new compounds 1,2 (Figure 1) along with three known compounds 3–5 [10–12]. 
Furthermore, the cytotoxic activity of these compounds against HCT-116 and SW-620 cells is reported 
for the first time.  
Figure 1. The structures of compounds 1–5. 
 
2. Results and Discussion 
Compound 1 was obtained as a white powder, whose molecular formula C18H26O8 was indicated by 
HR-TOF-MS at m/z 393.1525 [M+Na]
+ (calcd for C18H26O8Na, 393.1525), implying six degrees of 
unsaturation. The max absorptions in the UV spectrum of 1 were observed at 290, 259, 213 nm (in 
CH3OH). The IR spectrum of 1 showed absorption bands of hydroxyl (3496, 3444, 3367 cm
−1), 
aromatic ring (1510, 1454 cm
−1), and olefinic (1649 cm
−1) functionalities. The 
1H-NMR spectra of 1 
(Table 1) in CD3OD showed signals attributed to an aromatic ring ABX coupled system at ä 7.15(1H, 
d, J = 8.35 Hz, H-5), 7.11(1H, d, J = 1.90 Hz, H-2) and 6.99 (1H, dd, J = 1.90, 8.35 Hz, H-6), together 
with signals attributed to an aromatic methoxy group at ä 3.90 (3H, s), The presence of a 
trans-arylpropenoxy unit was characterized by signals at ä 6.61 (1H, d, J = 15.9 Hz, H-7), 6.26 (1H, dt, 
J = 6.15, 15.9 Hz, H-8) and 4.15 (2H, dd, J = 1.25, 6.15 Hz, H-9). Meanwhile, an ethoxyl unit was Molecules 2013, 18 4768 
 
indicated by signals of 3.60 (2H, q, J = 7.05 Hz, H-1'), 1.25(3H, t, J = 7.05 Hz, H-2'), In addition, a 
doublet assignable to an anomeric proton at  4.93 (1H, d, J = 7.25 Hz, H-1''), together with partially 
overlapped signals attributed to oxymethylene and oxymethine protons at  3.90 (1H, dd, H-6a''), 3.72 
(1H, dd, J = 7.45, 12.0 Hz, H-6b''), 3.52 (1H, m, H-2''), 3.51 (1H, m, H-3''), 3.50 (1H, m, H-5''), 3.48 
(1H, m, H-4''), suggested that there was a glycosyl moiety with a  configuration in 1. Enzymatic 
hydrolysis of 1 produced a sugar, which was identified as glucose by its 
1H-NMR data and TLC 
comparison with an authentic sugar sample. The glucose isolated from the hydrolysate gave a positive 
optical rotation [α]
20 
D : +47.2, indicating that it was D-glucose [13]. The 
13C-NMR and DEPT spectra of 
1 showed carbon signals corresponding to the above units (Table 1). The HMBC correlation signals 
(Table 1 and Figure 2) of H-1'' (δH 4.93)/C-4 (δC 147.96) indicated that the glucosyl group was linked 
to C-4, H-7 (δH 6.61)/C-1 (δC 133.38), C-2 (δC 111.59), C-6 (δC 121.0) indicated that the 
trans-arylpropenoxy unit was connected to the aromatic ring via a C-7C-1 bond, H-1' (δH 3.60)/C-9 
(δC 72.38) indicated that the ethoxyl unit was linked to C-9. Therefore, compound 1, whose 
1H-NMR 
and 
13C-NMR were similar to those of methylconiferin [14], was named ethylconiferin. 
Figure 2. Key HMBC correlations in compound 1. 
 
Table 1. 
1H-NMR (500 MHz) and 
13C-NMR (125 MHz) spectral data and HMBC 
Correlations of Compound 1 in CD3OD. 
NO.  δC  δH (J, Hz)  HMBC 
1  133.38    
2  111.59  7.11 (1H, d, 1.9)  4, 6 
3  151.07    
4  147.96    
5  118.08  7.15 (1H, d, 8.35)  1, 3 
6  121.0  6.99 (1H, dd, 1.9, 8.35)  1, 2, 4, 5 
7  133.55  6.61 (1H, d, 15.9)  1, 2, 6, 9 
8  126.13  6.26 (1H, dt, 6.15, 15.85)  1, 9 
9  72.38  4.15 (2H, dd, 1.25, 6.15)  1, 1', 8 
1'  66.78  3.60 (2H, q, 7.05)  2', 9 
2'  15.59  1.25 (3H, t, 7.05)  1' 
1''  102.89  4.93 (1H, d, 7.25)  4 
2''  75.05  3.52 (1H, m)  1'', 3'' 
3''  78.00  3.51 (1H, m)  2'', 4'' 
4''  71.49  3.48 (1H, m)  5'' 
5''  78.38  3.50 (1H, m)   
6a' 
62.66 
3.90 (1H, dd)   
6b''  3.72 (1H, dd, 7.45, 12)   
3-OCH3  56.87  3.90 (3H, s)  3 Molecules 2013, 18 4769 
 
Compound 2 was isolated as a white powder, whose molecular formula C35H40O12 was determined by 
HR-TOF-MS at m/z 653.2589 [M+H]
+ (calcd for C35H41O12, 652.2590), The UV absorption bands of 2 
appeared at 278, 216 and 203 nm in CH3OH. The IR spectrum of 2 showed the presence of hydroxyl 
(3498, 3458, 3384 cm
−1), conjugated-ester carbonyl (1714 cm
−1), α,β-unsaturated olefinic (1645, 1635 cm
−1) 
and aromatic ring (1512, 1456 cm
−1) functionalities. The 
1H-NMR data of 2 (Table 2) demonstrated 
signals attributable to two pairs of 1,3,4-trisubstituted benzene ring signals at δ 7.04 (1H, d, J = 8.25 Hz, 
H-5), 6.85 (1H, d, J = 1.75 Hz, H-2), 6.61 (1H, dd, J = 1.8, 8.25 Hz, H-6) and 6.90 (1H, d, J = 1.4 Hz, 
H-2'), 6.78 (1H, m H-5'), 6.77 (1H, m, H-6'); and a set of cinnamyl proton signals at δ 7.61 (2H ,m, H-2'', 
6''), 7.43 (3H, m, H-3'', 4'', 5''), 7.68 (1H, d, J = 16 Hz, H-7''), 6.56 (1H, d, J = 16 Hz, H-8'') in the 
aromatic region. In addition, resonances assignable to two aromatic methoxyl proton signals at δ 3.86 
(3H, s, 3'-OCH3), 3.85 (3H, s, 3-OCH3), and an anomeric proton signal at δ 4.88 (1H, d, H-1''') were 
observed. Furthermore, in the 
1H-NMR spectrum, an O-bearing methine proton signals at δ 4.72 (1H, d, 
J = 6.65 Hz, H-7'), an aliphatic methylene proton signals at δ 2.85 (1H, dd, J = 4.7, 13.5 Hz, H-7a), 2.38 
(1H, dd, 11.55, 13.3Hz, H-7b), two oxygenated methylene proton signals at δ 3.88(1H, dd, J = 6.5, 8.35 Hz, 
H-9a), 3.62 (1H, m, H-9b), 3.76 (1H, m, H-9a'), 3.60 (1H, m, H-9b'), and two aliphatic methine proton 
signals at δ 2.59 (1H, m, H-8), 2.31 (1H, m, H-8') were indicated. Besides the carbon resonances 
corresponding to the above units, the 
13C-NMR spectrum (Table 2) and the DEPT indicated the presence 
of conjugated-ester carbonyl carbon signals at δ 168.37 (C-9''); a set of a β-glucose moiety carbon 
signals at δ 102.87 (C-1'''), 77.95 (C-3'''), 75.61 (C-5'''), 75.03 (C-2'''), 72.13 (C-4'''), 64.96 (C-6'''). The 
key HMBC correlations (Table 2 and Figure 3) from 3-OCH3 to C-3; from 3'-OCH3 to C-3'; from H-7 to 
C-1, C-2, C-6, C-8 and C-9; from H-9 to C-7, C-7', C-8 and C-8'; from H-7' to C-1', C-2', C-6', C-8', C-9 
and C-9'; from H-8' to C-1', C-7, C-7', C-8, C-9 and C-9'; and from H-9' to C-7, C-7', C-8 and C-8'; 
suggested that the aglycone should be lariciresinol [15]. Moreover, the HMBC correlations of H-1'''/C-4 
confirmed that anomeric protons of β-glucose moiety was coupled with C-4. Meanwhile, the more 
deshielded proton of H-6''' (δH 4.55 and 4.33) exhibited a HMBC correlation with C-9'', which confirmed 
that the cinnamyl moiety was linked to C-6'''. In the NOESY spectrum of 2 (Figure 3), H-8' showed NOE 
correlations with H-2', H-6' and H-8, this experiment confirmed that H-8 and H-8' are in 
cis-configuration, meanwhile, H-7' and H-8' are in trans-configuration. Comparison of the NMR data of 
(−)-lariciresinol 4'-(6''-O-feruloyl-β-D-glucopyranoside) [16] and compound 2 indicated they had very 
similar aglycone and sugar moieties, the only difference being the presence of a cinnamyl moiety instead 
of a feruloyl group. Compound 2 was hydrolysed by dilute acid, and the hydrolysate was identified to be 
D-glucose by the same way as described in the case of 1, Therefore the structure of 2 was determined to 
be (−)-lariciresinol 4-(6'''-O-cinnamyl-β-D-glucopyranoside). 
Figure 3. Key HMBC and NOESY correlations in compound 2.  
 Molecules 2013, 18 4770 
 
Table 2. 
1H-NMR (500 MHz) and 
13C-NMR (125 MHz) spectral data and HMBC 
correlations of compound 2 in CD3OD. 
No.  δC  δH (J, Hz)  HMBC 
1  137.19    
2  114.46  6.85 (1H, d, 1.75)  1, 3, 4, 6, 7 
3  150.95    
4  146.21    
5  118.42  7.04 (1H, d, 8.25)  1, 2, 3, 4 
6  122.34  6.61 (1H, dd, 1.8, 8.25)  2, 3, 4, 5, 7 
7a 
33.85 
2.85 (1H, dd, 4.7, 13.5)  1, 2, 6, 8, 9 
7b  2.38 (1H, dd, 11.55, 13.3)  1, 2, 6, 8 
8  43.66  2.59 (1H, m)   
9a 
73.53 
3.88 (1H, dd, 6.5, 8.35)  7, 7', 8' 
9b  3.62 (1H, m)  7, 7', 8, 8' 
1'  135.87    
2'  110.78  6.90 (1H, d, 1.4)  1', 3', 4', 6', 7' 
3'  149.14    
4'  147.2    
5'  116.15  6.78 (1H, m)  1', 3', 4' 
6'  119.93  6.77 (1H, m)  2', 8' 
7'  84.11  4.72 (1H, d, 6.65)  1', 2', 6', 8', 9, 9' 
8'  54.15  2.31 (1H, m)  1', 7, 7', 8, 9, 9' 
9a' 
60.59 
3.76 (1H, m)  7, 7', 8, 8' 
9b'  3.60 (1H, m)  7, 7', 8, 8' 
1''  135.90    
2'',6''  129.47  7.61 (2H, m)  4'', 7'' 
3'',5''  130.28  7.43 (2H, m)  1'' 
4''  131.75  7.43 (1H, m)  1'', 3'', 5'' 
7''  146.59  7.68 (1H, d, 16)  1'', 2'', 6'', 8'', 9'' 
8''  118.96  6.56 (1H, d, 16)  1'', 9'' 
9''  168.37    
1'''  102.87  4.88 (1H, d)  4 
2'''  75.03  3.53 (1H, m)  1''', 4''' 
3'''  77.95  3.52 (1H, m)  2''', 4''' 
4'''  72.13  3.43 (1H, t)  3''', 5''', 6''' 
5'''  75.61  3.72 (1H, m)  1''', 4''', 6''' 
6a''' 
64.96 
4.55 (1H, dd, 2.2, 11.75)  5''', 9'' 
6b'''  4.43 (1H, dd, 7.4, 11.65)  5''', 9'' 
3-OCH3  56.85 3.85  3 
3’-OCH3  56.55 3.86  3' 
The known compounds 3–5 were identified by comparison of their spectroscopic data with literature 
values. HCT-116 and SW-620 cells were treated with three different concentrations of compounds for 
24 h. The antiproliferative effects of the five compounds on HCT-116 and SW-620 cells are shown in 
Table 3. None of the tested compounds had any significant effects on proliferation of HCT-116 cells and 
SW-620 cells at the tested concentrations of 1–10 M. Molecules 2013, 18 4771 
 
Table 3. Activity of compounds 1–5 on proliferation of the HCT-116 and SW-620 cells. 
  HCT-116 cells  SW-620 cells 
Sample 
10
−4 mol/L  10
−5 mol/L  10
−6 mol/L  10
−4 mol/L  10
−5 mol/L  10
−6 mol/L 
Inhibitory rate 
(%) 
Inhibitory rate 
(%) 
Inhibitory rate 
(%) 
Inhibitory rate 
(%) 
Inhibitory rate 
(%) 
Inhibitory rate 
(%) 
1  5.383 ± 2.187 **  16.150 ± 0.504 **  13.329 ± 0.367 **  6.967 ± 0.262 **  5.026 ± 0.713 **  1.218 ± 1.016 ** 
2  13.049 ± 1.607 **  14.685 ± 1.615 **  11.671 ± 0.941 **  12.260 ± 0.443 **  3.141 ± 1.101 **  2.894 ± 0.461 ** 
3  12.086 ± 1.404 **  13.157 ± 0.748 **  5.943 ± 0.931 **  24.119 ± 1.128 **  8.605 ± 0.745 **  5.863 ± 0.287 ** 
4  14.750 ± 2.171 **  6.288 ± 1.735 **  3.725 ± 0.914 **  24.481 ± 0.184 **  2.894 ± 0.960 **  6.035 ± 0.605 ** 
5  19.079 ± 0.440 **  13.868 ± 0.373 **  2.972 ± 0.734 **  26.499 ± 0.453 **  3.769 ± 0.799 **  2.646 ± 1.577 ** 
Control  0 0 0 0 0 0 
The data are expressed as mean ± SD of three independent experiments. (** p < 0.01 vs. control). 
3. Experimental 
3.1. General 
UV spectra were taken with a HALO DB-20R UV-VIS spectrophotometer. Optical rotations were 
recorded on a PerkinElmer Model 343 polarimeter. The IR spectra were recorded on a Shimadzu 
FTIR-8400S instrument. ESI-MS was performed on s Waters Quattro Premier instrument. The 
HR-ESIMS spectra was taken on an Agilent Technologies 6550 Q-TOF. 1D and 2D NMR spectra were 
recorded on a Bruker-AVANCE500 instrument with TMS as an internal standard. The analytical HPLC 
was performed on a Waters 2695 Separations Module coupled with a 2996 Photodiode Array Detector and a 
ODS-3 column (4.6 × 250 mm, 5 ìm particles, Inertsill, Tokyo, Japan). Semipreparative HPLC was 
performed on a system comprising a Shimadzu LC-6AD pump equipped with a SPD-20A UV detector 
and a Ultimate XB-C18 (10 × 250 mm, 5 μm particles) or Allsphere ODS-2 (10 × 250 mm, 5 μm 
particles). Sephadex LH-20 was purchased from GE Healthcare Bio-Sciences AB (Uppsala, Sweden). 
MCI GEL was from Mitsubishi Chemical Corporation (Tokyo, Japan). C-18 (40–75 μm) silicagel was 
purchased from SiliCycle Corporation (Quebec, Canada). D101 was from Sunresin New Materials Co. 
Ltd. (Xi’an, China). Silica gel was purchased from Qingdao Haiyang Chemical Group Corporation 
(Qingdao, China). 
3.2. Plant Materials 
The root of Jasminum giraldii Diels. was collected on October in 2009 in Shanxi, China, and 
authenticated by Prof. Yaowu Guo. A voucher specimen has been deposited in the Department of 
Collaborative Innovation Center for Chinese Medicine in Qingba Mountains, School of Pharmacy the 
Fourth Military Medical University. 
3.3. Extraction and Isolation 
The root of J. giraldii (20 kg) was powdered and extracted with EtOH (100 L, 3 h × 4) under reflux. 
Evaporation of the solvent under reduced pressure gave the EtOH extract. The combined extract was 
applied to D101 and eluted with EtOH-H2O to obtain the 95% EtOH eluate (15 L). The eluate was Molecules 2013, 18 4772 
 
evaporated under vacuum and freeze dried to yield a powder (895 g), which was suspended in H2O and 
partitioned successively with petroleum ether, EtOAc and n-BuOH. The EtOAc fraction was subjected 
to silica-gel column chromatography eluting with CHCl3-MeOH (100:0 to 1:1) to obtain 33 fractions 
(Fr.1–Fr.33). Fr.28 was further separated by flash chromatography over MCI, eluting with a gradient of 
MeOH (0–100%) in H2O to obtain seven fractions (Fr.28-1–Fr.28-7). Repeated chromatography of 
Fr.28-1 with silica gel (MeOH/CHCl3, 30:1–5:1), Sephadex LH-20 (CHCl3/MeOH, 1:1), prep-TLC and 
prep-HPLC gave compounds 1 (8 mg), 2 (26 mg), 4 (28 mg), Fr.21 was subjected to silica gel  
(200–300 mesh) column chromatography and eluted with CHCl3/MeOH (100:0–50:1) to obtain five 
fractions (Fr.21-1–Fr.21-5). Fr.21-5 was further separated repeated with silica gel column (petroleum 
ether/acetone, 8:1–5:1), Sephadex LH-20 (CHCl3/MeOH, 1:1), prep-TLC and prep-HPLC to afford 
compounds 3 (120 mg) and 5 (5 mg). 
3.4. Spectral Data 
Ethylconiferin (1): white powder; C18H26O8; [α]
20 
D : −19.76 (c 0.1, CH3OH); UVmax (MeOH) λmax 290, 
259 and 213 nm; IR (KBr) νmax 3496, 3444, 3367, 2979, 2939, 2867, 1649, 1510, 1454, 1128, 1089, 
1047, 1027 cm
−1; HR-TOF-MS m/z 393.1525 [M+Na]
+ (calcd for C18H26NaO8; 393.1525); 
1H-NMR 
(500 MHz, CD3OD) and 
13C-NMR (125 MHz, CD3OD) data, see Table 1. 
(−)-Lariciresinol 4-(6'''-O-cinnamyl-β-D-glucopyranoside) (2): white powder; C35H40O12; [α]
20 
D : −10.91 
(c 0.1, MeOH); UVmax (MeOH) λmax 278, 216 and 203 nm; IR(KBr) νmax 3498, 3458, 3384, 2925, 2854, 
1714, 1645, 1635, 1512, 1456, 1269, 1226, 1161, 1124, 1105, 1072, 1035 cm
−1; HR-TOF-MS m/z 
653.2590 [M+H]
+ (calcd for C35H41O8; 653.2590); 
1H-NMR (500 MHz, CD3OD) and 
13C-NMR (125 MHz, 
CD3OD) data, see Table 2. 
(+)-Pinoresinol (3): yellow powder; C20H22O6; [α]
20 
D : +46.0 (c 0.1, MeOH); UVmax (MeOH) λmax 280, 
231 and 207 nm; IR (KBr) νmax 3504, 3438, 3379, 2958, 2939, 2860, 1604, 1514, 1460, 1438, 1271, 
1029 cm
−1; ESI-MS m/z 357 [M−H]
; 
1H-NMR (500 MHz, Me2CO-d6) δ 7.47 (2H, s, 4-OH and 4'-OH), 
6.99 (2H, d, J = 1.7 Hz, H-2, 2'), 6.84 (2H, dd, J = 1.7, 8.1 Hz, H-6, 6'), 6.79 (2H, d, J = 8.1 Hz, H-5, 
5'),4.67 (2H, d, J = 4.15 Hz, H-7, 7'), 4.20 (2H, dd, J = 6.95, 8.95 Hz, H-9a, 9'a), 3.84(6H, s, 3-OCH3 and 
3'-OCH3), 3.81 (2H, dd, J = 3.7, 9.1 Hz, H-9b, 9'b), 3.08 (2H, m, H-8, 8'); 
13C-NMR (125 MHz, 
Me2CO-d6) δ 148.40 (C-3, 3'), 146.94 (C-4, 4'), 134.27 (C-1, 1'), 119.69 (C-6, 6'), 115.62 (C-5, 5'), 
110.67 (C-2, 2'), 86.72 (C-7, 7'), 72.29 (C-9, 9'), 56.33 (3-OCH3 and 3'-OCH3), 55.32 (C-8, 8'). 
(+)-Cycloolivil (4): yellow powder; C20H24O7; [α]
20 
D : +43.2 (c 0.1, MeOH); UVmax (MeOH) λmax 283, 230 
and 204 nm; IR (KBr) νmax 3517, 3444, 3313, 3201, 2939, 2900, 2835, 1699, 1598, 1517, 1465, 1446, 
1433, 1373, 1269, 1236, 1215, 1149, 1124, 1022, 881, 858, 838, 811 cm
−1; ESI-MS m/z 375 [M−H]
; 
1H-NMR (500 MHz, CD3OD) δ 6.76 (1H, d, J = 8.0 Hz, H-5), 6.76 (1H, d, J = 1.6 Hz, H-2), 6.67 (1H, 
dd, J = 1.7, 7.95 Hz, H-6), 6.63 (1H, s, H-5'), 6.18 (1H, s, H-2'), 4.03 (1H, d, J = 11.65 Hz, H-7), 3.80 
(3H, s, OCH3), 3.77 (2H, m, H-9a, 9'a), 3.74 (3H, OCH3), 3.59 (2H, m, H-9b, 9'b), 3.23 (1H, d, J = 16.65 
Hz, H-7'a), 2.62 (1H, d, J = 16.65 Hz, H-7'b), 2.04 (1H, m, H-8); 
13C-NMR (125 MHz, CD3OD) δ 
149.27 (C-3), 147.64 (C-3'), 146.25 (C-4), 145.44 (C-4'), 138.62 (C-1'), 133.69 (C-1), 126.57 (C-6'), Molecules 2013, 18 4773 
 
123.71 (C-6), 117.48 (C-5), 116.15 (C-5'), 114.06 (C-2), 113.09 (C-2'), 75.10 (C-8'), 69.55 (C-9), 60.98 
(C-9'), 56.52 (OCH3), 56.49 (OCH3), 47.69 (C-8), 45.03 (C-7), 40.06 (C-7'). 
Nobiletin (5): white powder; C9H12O2; [α]
20 
D : +3.69 (c 0.1, MeOH); UVmax (MeOH) λmax 328, 269, 249 
and 208 nm. IR (KBr) νmax 2947, 2854, 1629, 1598, 1514, 1461, 1377, 1278, 1149, 1107, 1078, 1012, 
973, 838 cm
−1; ESI-MS m/z 403 [M+H]
+; 
1H-NMR (500 MHz, Me2CO-d6)  δ 7.66 (1H, dd,   
J = 2.15, 8.5 Hz, H-6'), 7.59 (1H, d, J = 2.05 Hz, H-2'), 7.15 (1H, d, J = 8.5 Hz, H-5'), 6.62 (1H, s, H-3), 
4.07 (3H, s, OCH3), 4.04 (3H, s, OCH3), 3.96 (3H, s, OCH3), 3.92 (3H,s, OCH3), 3.89 (3H, s, OCH3), 
3.85 (3H, s, OCH3); 
13C-NMR (125 MHz, Me2CO-d6) δ 176.74 (C-4), 161.67 (C-2), 153.38 (C-4'), 152.4 
(C-7), 150.72 (C-3'), 149.22 (C-9), 148.64 (C-8), 145.15 (C-5), 139.24 (C-6), 124.85 (C-1'), 120.39 
(C-6'), 115.91 (C-10), 112.69 (C-5'), 110.01 (C-2'), 107.29 (C-3), 62.44, 62.37, 62.04, 61.98, 56.34, 
56.31(5-OCH3 6-OCH3, 7-OCH3, 8-OCH3, 3'-OCH3 and 4'-OCH3,). 
3.5. Enzymatic Hydrolysis of 1 
A solution of compound 1 in H2O (3 mL) was hydrolysed with β-glucosidase (10 mg, Almonds Lot 
1264252, Sigma-Aldrich, St. Louis, MO, USA) at 37 °C for 24 or 36 h. The reaction mixture was 
extracted with EtOAc for three times (3 × 3 mL) to yield the EtOAc exrract and H2O phase after 
removing the solvents. The aqueous phase of the hydrolysate of compound 1 was subjected to CC over 
silica gel eluted with MeCN/H2O (8:1) to yield glucose with positive optical rotations, and the value of 
[α]
20 
D : was +47.2 (c 0.16, H2O). The solvent system MeCN/H2O (6:1) was used for the TLC analysis of 
glucose and authentic sugar samples. 
3.6. Acid Hydrolysis of 2 
A solution of compound 2 in 0.5 M H2SO4 (2.0 mL) was heated under reflux for 3 h. After cooling, 
the reaction mixture was diluted with H2O, neutralized with BaCO3, then filtered. The solution was 
extracted with EtOAc for three times (3 × 3 mL) to obtained the EtOAc extract and H2O layer after 
removing the solvents. The aqueous layer of the hydrolysate of compound 2 was evaporated and to 
yield glucose with positive optical rotations, and the value of [α]
20 
D : was +42.5 (c 0.11, H2O). The solvent 
system MeCN/H2O (6:1) was used for the TLC analysis of glucose and authentic sugar samples. 
3.7. Bioassay for Cytotoxic Activity 
The human colon cell line HCT-116 and SW620 was obtained from the Shanghai Institute of Cell 
Biology. The cells were maintained in DMEM medium supplemented with 10% FBS, penicillin (100 U/mL) 
and streptomycin (100 mg/mL) at 37 °C in a humidified atmosphere with 5% CO2. Cell proliferation of 
HCT-116 cells was assessed by conducting colorimetric MTT cell proliferation assay. Briefly, a limited 
number of growing cells were seeded into 96-well cell culture plate and were maintained for 24 h so that 
they became attached to the bottom of the well. The medium was aspirated and new medium (200 µL) 
including three groups of concentrations (10
−4, 10
−5, 10
−6 M) of compounds were added to parallel wells. 
The cells were incubated at 37 °C in a humidified atmosphere for 24 h. Twenty µL of MTT solution was 
added and the incubation continued for 4 h. The pure formazan product was then solubilized by 150 µL 
DMSO. The plates were read at 570 nm using a microtiter plate reader. Molecules 2013, 18 4774 
 
4. Conclusions 
Compounds 1, 2 were new glycosides and together with compounds 3–5 were isolated from the 
Jasminum genus for the first time. Compounds 1–5 were assayed for their cytotoxic activity, and the data 
proved that none of the compounds had any significant inhibitory activities on proliferation of HCT-116 
cells and SW-620 cells at the concentrations of 1–10 M. 
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